Skip to main content
eScholarship
Open Access Publications from the University of California

Characterization of Caspase-8 and p85alpha in Ovarian Cancer /

  • Author(s): Chen, Lauren Elizabeth
  • et al.
Abstract

Caspase-8 is a cytosolic cysteine protease that induces programmed cell death by processing a variety of apoptotic substrates [1]. Conversely, it has been shown to have non- apoptotic functions and is upregulated in many cancers, including ovarian cancer [2, 3]. In neuroblastoma cells, post-translational modification of caspase-8 by tyrosine phosphorylation has been shown to promote cell adhesion and migration, which are hallmarks of cancer cells [2, 4, 5]. Phosphorylated tyrosine residues may bind to SH2 (src homology 2) domains, which are present in 121 human proteins, and may be involved in caspase-8 dependent migration. The regulatory subunit of PI3K (phosphoinositide-3 kinase) p85[alpha] contains two SH2 domains, and has been previously suggested to be involved in migration [2]. Here, I characterize a direct and typical SH2-phosphotyrosine interaction between the Y380 of caspase-8 and the nSH2 domain of p85[alpha] in ovarian cancer cells. In addition, caspase-8 appears to promote adhesion in ovarian cancer cells, but potentially in a manner that is independent of the Y380 site. Protein modeling of caspase-8/p85p85[alpha]/p110[alpha] reveals potential mechanisms in which such an interaction could affect PI3K signaling. Understanding the implications of a caspase-8 and p85[alpha] interaction may further clarify the mechanisms by which caspase-8's dual roles are regulated, providing insight into the paradoxical retention of the caspase during tumor progression, as well as for therapies directed at optimizing tumor cell death.

Main Content
Current View